Vitrification of Mature Mouse Oocytes in a 6 M Me2SO Solution Supplemented with Antifreeze Glycoproteins: The Effect of Temperature

• Published in: Cryobiology Vol. 37; no. 1; pp. 59 - 66
• Main Authors: O'Neil, L., Paynter, S.J., Fuller, B.J., Shaw, R.W., DeVries, A.L.
• Format: Journal Article
• Language: English
• Published: San Diego, CA Elsevier Inc 01.08.1998; Elsevier
• Subjects: Animals; antifreeze glycoproteins; Biological and medical sciences; Biological material (laboratory animals, preparation of biological tracers, etc.); Cryopreservation; Cryoprotective Agents; Dimethyl Sulfoxide; Embryology: invertebrates and vertebrates. Teratology; Female; Fundamental and applied biological sciences. Psychology; General aspects; General aspects. Development. Fetal membranes; Mice; mouse oocyte; Oocytes; Temperature; vitrification; dimethyl sulfoxide; antifreeze glycoproteins; mouse oocyte; vitrification; Treatment efficiency; Vitrification; Rodentia; Fecundation; In vitro; Cryobiology; Vertebrata; Mammalia; Mouse; Cryopreservation; Dimethyl sulfoxide; Cryoprotective agent; Antifreeze protein; Viability; Oocyte
• ISSN: 0011-2240; 1090-2392
• DOI: 10.1006/cryo.1998.2098

Oocytes have been successfully cryopreserved using rapid and slow freezing procedures. However, variability in the success of replicates has limited its practical application. In the present study, mature mouse oocytes were vitrified in 6 M dimethyl sulfoxide supplemented with 1 mg/ml antifreeze glycoproteins (AFGP) (solution known as VSD + AFGP) from the blood of Antarctic notothenioid fish. Such AFGPs have been used to protect mammalian cells during hypothermia and cryopreservation. However, the degree of protection afforded is a contentious issue. Stepwise addition of cryoprotectant was performed either at room temperature (19–21°C) or on ice (2–4°C), at the final stage of which oocytes were pipetted into 0.25 ml plastic insemination straws and held in liquid nitrogen vapor at −140°C for 3 min before being plunged into liquid nitrogen. Thawing involved holding the straw in the air for 10 s and then in water at 20°C for 10 s before dilution of the VSD solution with 1 M sucrose. Viability was assessed byin vitrofertilization; results have been quoted as median (range). Statistical analyses were performed using Kruskall–Wallis and Mann–WhitneyUtests (P< 0.05). Of the oocytes cryopreserved following exposure to VSD + AFGP at room temperature (n= 518, 15 experimental runs), 78% (0–94%) retained normal morphology and, of these, 53% (0–100%) cleaved to two cells. Of these two-cell embryos, 56% (0–100%) went on to develop to blastocyst. The overall percentage development to blastocyst, i.e., number of blastocysts/total number of oocytes treated × 100, was 20% (0–76%). Exposure of oocytes to the VSD + AFGP on ice prior to cryopreservation yielded significantly improved rates of fertilization (94%, 82–100%) and overall development to blastocyst (66%, 24–89%) when compared with oocytes cryopreserved following exposure to the VSD + AFGP at room temperature. Rates of normality (86%, 35–95%) and development to blastocyst (89%, 64–100%) were also improved. Cryopreservation in 6 M dimethyl sulfoxide supplemented with 1 mg/ml AFGP resulted in poor rates of survival which were highly variable when exposure to cryoprotective agent (CPA) was performed at room temperature. Lowering the temperature of exposure to CPA prior to cryopreservation resulted in improved viability.